{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:11Z","timestamp":1786985231787,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873194"],"award-info":[{"award-number":["81873194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903938"],"award-info":[{"award-number":["81903938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111846","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T13:49:35Z","timestamp":1625233775000},"page":"111846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Pharmacodynamic substances in Salvia miltiorrhiza for prevention and treatment of hyperlipidemia and coronary heart disease based on lipidomics technology and network pharmacology analysis"],"prefix":"10.1016","volume":"141","author":[{"given":"Guijiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianpu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111846_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.tibs.2016.08.010","article-title":"Lipidomics: techniques, applications, and outcomes related to biomedical sciences","volume":"41","author":"Yang","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40169-018-0190-9","article-title":"Clinical lipidomics: a new way to diagnose human diseases","volume":"7","author":"LV","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbalip.2017.04.002","article-title":"Lipidomics in biomedical research-practical considerations","volume":"1862","author":"Hy\u00f6tyl\u00e4inen","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.biopha.2021.111846_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/ijms20051051","article-title":"Lipidomics of bioactive lipids in acute coronary syndromes","volume":"20","author":"Solati","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/pr060256p","article-title":"Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC\/Q-TOF MS)","volume":"5","author":"Yin","year":"2006","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.biopha.2021.111846_bib6","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1021\/pr100101p","article-title":"Metabolic profiling of plasma in overweight\/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS)","volume":"9","author":"Kim","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2021.111846_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111846_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"Griffin","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2021.111846_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2021.111846_bib10","first-page":"2245","article-title":"Application status and proposals of network pharmacology in study on traditional chinese medicine","volume":"24","author":"Wang","year":"2013","journal-title":"LiShiZhen. Med. Mater. Med. Res."},{"key":"10.1016\/j.biopha.2021.111846_bib11","first-page":"883","article-title":"Progress in network pharmacology for modern research of traditional Chinese medicine","volume":"29","author":"Zhang","year":"2015","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2021.111846_bib12","first-page":"157","article-title":"Primary osteoporosis","volume":"28","author":"Arundel","year":"2015","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.biopha.2021.111846_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano","year":"2010","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2021.111846_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","article-title":"Monocytes in coronary artery disease and atherosclerosis: where are we now?","volume":"62","author":"Ghattas","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.111846_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis","volume":"183","author":"Jaina","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.111846_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/ijms21020552","article-title":"Beneficial effects of SREBP decoy oligodeoxynucleotide in an animal model of HL","volume":"21","author":"A","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.amjmed.2014.04.015","article-title":"The epidemic of the 20(th) century: coronary heart disease","volume":"127","author":"Dalen","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib18","first-page":"152","article-title":"Textual research on ancient literature of salvia miltiorrhiza efficacy henan university of traditionaland modern pharmacological knowledge","volume":"21","author":"Dong","year":"2019","journal-title":"J. Liaoning Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib19","first-page":"1251","article-title":"Effect of salvia miltiorrhiza on reducing inflammatory factor-inflammatory response","volume":"28","author":"Cao","year":"2019","journal-title":"Mod. J. Int. Tradit. Chin. West. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib20","first-page":"2271","article-title":"Research progress on metabolic pathways and products of main active ingredients of salvia miltiorrhiza in vivo","volume":"26","author":"Lin","year":"2017","journal-title":"Chin. New. Drugs J."},{"key":"10.1016\/j.biopha.2021.111846_bib21","article-title":"A Network Pharmacology Technique to Investigate the Synergistic Mechanisms of Salvia miltiorrhiza and Radix puerariae in Treatment of Cardio-Cerebral Vascular Diseases","volume":"6937186","author":"Ma","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.biopha.2021.111846_bib22","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1159\/000486154","article-title":"Salvianolic acid a protects against diabetic nephropathy through ameliorating glomerular endothelial dysfunction via inhibiting AGE-RAGE Signaling","volume":"44","author":"Hou","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2021.111846_bib23","doi-asserted-by":"crossref","first-page":"22288","DOI":"10.1074\/jbc.M115.712703","article-title":"Effects of the Nrf2 protein modulator salvianolic acid A alone or combined with metformin on diabetes-associated macrovascular and renal injury","volume":"291","author":"Wu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111846_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ebiom.2019.01.065","article-title":"Oxidized LDL upregulates macrophage DPP4 expression via TLR4\/TRIF\/CD36 pathways","volume":"41","author":"Rao","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2021.111846_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/lipd.12106","article-title":"Determination of the phosphatidylcholine\/ lysophosphatidylcholine ratio in intact serum by matrix-assisted laser desorption\/ionization mass spectrometry with prior enzymatic albumin digestion","volume":"53","author":"Ditz","year":"2018","journal-title":"Lipids"},{"key":"10.1016\/j.biopha.2021.111846_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02882899","article-title":"A mechanism underlying stimulation and inhibition of protein kinase C by lyso-PC: A role of membrane physical state","volume":"41","author":"Pan","year":"1998","journal-title":"Sci. China C. Life. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1536\/ihj.19-059","article-title":"Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease","volume":"60","author":"Fu","year":"2019","journal-title":"Int. Heart J."},{"key":"10.1016\/j.biopha.2021.111846_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155028","article-title":"Pro-inflammatory cytokines, oxidative stress and diffuse coronary reocclusions in elderly patients after coronary stenting","volume":"129","author":"Li","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2021.111846_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2019.09.017","article-title":"Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish","volume":"290","author":"Luo","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111846_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/VHRM.S202344","article-title":"Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease","volume":"15","author":"Djekic","year":"2019","journal-title":"Vasc. Health Risk. Manag."},{"key":"10.1016\/j.biopha.2021.111846_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cdd.2014.219","article-title":"Phosphatidylethanolamine positively regulates autophagy and longevity","volume":"22","author":"Rockenfeller","year":"2015","journal-title":"Cell. Death. Differ."},{"key":"10.1016\/j.biopha.2021.111846_bib32","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1373\/clinchem.2008.107359","article-title":"Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study","volume":"54","author":"Brilakis","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2021.111846_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"GigaScience"},{"key":"10.1016\/j.biopha.2021.111846_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2014.01.002","article-title":"Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and sphingolipid species","volume":"54","author":"Ecker","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111846_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.111846_bib36","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinbergb","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111846_bib37","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111846_bib38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111846_bib39","doi-asserted-by":"crossref","first-page":"15357","DOI":"10.1038\/s41598-017-15737-3","article-title":"Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF\/MS-based metabolomics approach","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111846_bib40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.111846_bib41","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib42","doi-asserted-by":"crossref","first-page":"15357","DOI":"10.1038\/s41598-017-15737-3","article-title":"Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF\/MS-based metabolomics approach","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111846_bib43","first-page":"6261","article-title":"Metabolomics analysis reveals an effect of homocysteine on arachidonic acid and linoleic acid metabolism pathway","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111846_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2018.05.004","article-title":"Differentiating the biological effects of linoleic acid from arachidonic acid in health and disease","volume":"135","author":"Burns","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.biopha.2021.111846_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biochi.2013.07.012","article-title":"Linoleic acid: between doubts and certainties","volume":"96","author":"Choque","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2021.111846_bib46","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111846_bib48","first-page":"1525","article-title":"JNK and NF-\u03baB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure","volume":"15","author":"Fan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib49","first-page":"49","article-title":"Relationship between atherosclerosis and inflammation and related therapeutic drugs","volume":"37","author":"Song","year":"2013","journal-title":"Pro. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib50","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/ijms20246254","article-title":"Prostaglandin E2\/EP signaling in the tumor microenvironment of colorectal cancer","volume":"20","author":"Mizuno","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib51","first-page":"3","article-title":"Prostacyclin among prostanoids","volume":"60","author":"Gryglewski","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2021.111846_bib52","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1253\/circj.CJ-10-0195","article-title":"Prostacyclin in vascular diseases. - Recent insights and future perspectives","volume":"74","author":"Kawabe","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2021.111846_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0002-9149(81)90182-X","article-title":"Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality","volume":"47","author":"Ribeiro","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111846_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/cells9030581","article-title":"Sphingolipids and mitochondrial dynamic","volume":"9","author":"Fugio","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2021.111846_bib55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2012.09.032","article-title":"Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice","volume":"225","author":"Bou\u00e9","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111846_bib56","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1194\/jlr.R026682","article-title":"Role of sulfatide in normal and pathological cells and tissues","volume":"53","author":"Takahashi","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111846_bib57","first-page":"603","article-title":"Sphingomyelin metabolism, and atherosclerosis","volume":"7","author":"Jiang","year":"2014","journal-title":"Chin. J. Hypertens."},{"key":"10.1016\/j.biopha.2021.111846_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012885","article-title":"Sphingomyelin synthase 2 inhibition ameliorates cerebral ischemic reperfusion injury through reducing the recruitment of toll-like receptor 4 to lipid rafts","volume":"8","author":"Xue","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2021.111846_bib59","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2011.12.079","article-title":"Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation","volume":"417","author":"Kidani","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.111846_bib60","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/ijms20122861","article-title":"Sphingomyelin synthase 2 promotes endothelial dysfunction by inducing endoplasmic reticulum stress","volume":"20","author":"Hua","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111846_bib61","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/ATVBAHA.108.168682","article-title":"Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation","volume":"28","author":"Hailemariam","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111846_bib62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"ApoE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.111846_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2019.01.031","article-title":"Early rescue of lymphatic function limits atherosclerosis progression in Ldlr-\/-mice","volume":"283","author":"Milasan","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111846_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.foodchem.2017.09.092","article-title":"Thermodynamic and kinetic analyses of curcumin and bovine serum albumin binding","volume":"242","author":"Hudson","year":"2018","journal-title":"Food Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:31:23Z","timestamp":1776461483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221006284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":64,"alternative-id":["S0753332221006284"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111846","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic substances in Salvia miltiorrhiza for prevention and treatment of hyperlipidemia and coronary heart disease based on lipidomics technology and network pharmacology analysis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111846"}}